Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.27 | 0.2 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |